ArticleHeliyon2024

Combination therapy of targeting CD20 antibody and immune checkpoint inhibitor may be a breakthrough in the treatment of B-cell lymphoma.

Xin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.